| Partial Chest Wall Radiation Therapy After Surgery for Lymph Node Negative Breast Cancer (NCT05436808) | Stony Brook University | 2022-07-15 |
| Comparison Between Prepectoral and Subpectoral Breast Reconstruction (NCT05833659) | Beijing Friendship Hospital | 2022-03-01 |
| Ask Questions (ASQ):Implementation of a Communication Intervention (NCT05025748) | Barbara Ann Karmanos Cancer Institute | 2021-08-25 |
| Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer (NCT04553770) | Jonsson Comprehensive Cancer Center | 2020-10-09 |
| Researching the Effect of Exercise on Cancer (NCT04589468) | City of Hope Medical Center | 2020-10-02 |
| MARGetuximab Or Trastuzumab (MARGOT) (NCT04425018) | Dana-Farber Cancer Institute | 2020-07-13 |
| Extension Study to Provide Adjuvant Treatment Following Neoadjuvant Treatment and Surgical Resection in Protocol TX05-03 (NCT04109391) | Tanvex BioPharma USA, Inc. | 2019-08-20 |
| Exercise Intervention in Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Cancer (NCT03091842) | University of Southern California | 2019-07-29 |
| Acupuncture Pilot Study for Cancer-related Cognitive Function (NCT04007770) | Memorial Sloan Kettering Cancer Center | 2019-07-01 |
| Living Well After Breast Surgery (NCT03834532) | University of Texas at Austin | 2019-02-18 |
| Biomarker Study of the Antitumoral Activity of Denosumab in the Pre- Operative Setting of Early Breast Cancer (NCT03691311) | Institut Català d'Oncologia | 2018-07-05 |
| Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast Cancer (NCT03556358) | Tanvex BioPharma USA, Inc. | 2018-06-28 |
| HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer (NCT03387553) | H. Lee Moffitt Cancer Center and Research Institute | 2018-06-06 |
| Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer (NCT03414970) | Alliance for Clinical Trials in Oncology | 2018-03-12 |
| Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer (NCT03345420) | University of Utah | 2017-12-12 |
| Aerobic and Strength Training Exercise in Improving Fitness and Arm Health During and After Radiation Therapy in Patients With Stage II-III Breast Cancer (NCT03102866) | Ohio State University Comprehensive Cancer Center | 2017-08-30 |
| Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors (NCT03284346) | University of Southern California | 2017-08-17 |
| Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast Cancer (NCT03128619) | Jonsson Comprehensive Cancer Center | 2017-08-02 |
| Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery (NCT03113825) | Avelas Biosciences, Inc. | 2017-07-05 |
| Ultrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast Cancer (NCT03139435) | Wake Forest University Health Sciences | 2017-05-11 |
| Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery (NCT03188393) | NRG Oncology | 2017-04-13 |
| Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca (NCT02957968) | Virginia Commonwealth University | 2017-01-24 |
| Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in Remission (NCT02780401) | University of Washington | 2016-09-02 |
| Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy (NCT02445391) | ECOG-ACRIN Cancer Research Group | 2015-10-20 |
| Web-Based Decision Aid in Improving Informed Decisions in Patients With Stage 0-IIIA Breast Cancer Considering Contralateral Prophylactic Mastectomy (NCT03061175) | Rutgers, The State University of New Jersey | 2015-09-24 |
| Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors (NCT03198286) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2015-08-01 |
| Minocycline Hydrochloride in Reducing Chemotherapy Induced Depression and Anxiety in Patients With Stage I-III Breast Cancer (NCT02203552) | Ohio State University Comprehensive Cancer Center | 2015-06-23 |
| Comparison of Use of Indocyanine Green and 99mTc-labeled Radiotracer for Axillary Lymphatic Mapping in Patients With Breast Cancer (NCT02419807) | Case Comprehensive Cancer Center | 2015-02-17 |
| T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA (NCT02326974) | Dana-Farber Cancer Institute | 2015-01-01 |
| Energy Balance and Breast Cancer Aspects-II (NCT02240836) | Oslo University Hospital | 2014-09-01 |
| Neoadjuvant Trial of Capecitabine for Axillary Lymph Node Positive Operable Breast Cancer (NCT02115152) | Guangxi Medical University | 2014-06-01 |
| A Pilot Study of Acupuncture for Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients (NCT02129686) | Dana-Farber Cancer Institute | 2014-06-01 |
| MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer (NCT01805076) | Alliance for Clinical Trials in Oncology | 2014-05-21 |
| Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin (NCT02096588) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-05-20 |
| Interactive Gentle Yoga in Improving Quality of Life in Patients With Stage I-III Breast Cancer Undergoing Radiation Therapy (NCT02023008) | Wake Forest University Health Sciences | 2014-05-01 |
| Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery (NCT01953588) | Alliance for Clinical Trials in Oncology | 2014-02-27 |
| Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy (NCT01901094) | Alliance for Clinical Trials in Oncology | 2014-02-24 |
| Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy (NCT02002533) | Gary Morrow | 2014-02-03 |
| Health Education Intervention in Reducing Weight Gain in Patients With Newly Diagnosed Stage I-IV Breast Cancer Undergoing Chemotherapy (NCT01941784) | Wake Forest University Health Sciences | 2013-11-25 |
| PET/CT in Evaluating Response to Chemotherapy in Patients With Breast Cancer (NCT01712815) | University of Southern California | 2013-11-22 |
| Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer (NCT01869764) | Wake Forest University Health Sciences | 2013-11-01 |
| Trastuzumab and Pertuzumab or Bevacizumab With Combination Chemotherapy in Treating Patients With Stage II-III Breast Cancer (NCT01959490) | Case Comprehensive Cancer Center | 2013-09-24 |
| Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Prostate Cancer or Stage I-III Colorectal Cancer (NCT03233555) | Rutgers, The State University of New Jersey | 2013-09-03 |
| Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery (NCT01872975) | NSABP Foundation Inc | 2013-08-01 |
| A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS) (NCT01824836) | ECOG-ACRIN Cancer Research Group | 2013-06-11 |
| Oral CDB-4124 vs. Placebo in Stage I-II Primary Breast Cancer (NCT01800422) | Northwestern University | 2013-06-01 |
| Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery (NCT01754519) | Roswell Park Cancer Institute | 2013-05-01 |
| Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast Cancer (NCT01818063) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2013-04-25 |
| Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer (NCT01750073) | University of Nebraska | 2012-12-07 |
| Light-Scattering Spectroscopy for Detection of Breast Cancer (NCT01755208) | University of Southern California | 2012-11-21 |
| Phase I: At-Home Support for Rural Women Using Group Video Calling (NCT01672684) | Stanford University | 2012-10-01 |
| Vorinostat Before Surgery in Treating Patients With Triple-Negative Breast Cancer (NCT01695057) | University of Southern California | 2012-10-01 |
| Feasibility of a Supportive Education Program for Latina Breast Cancer Survivors (NCT01628887) | City of Hope Medical Center | 2012-08-01 |
| Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast Cancer (NCT01632332) | Mayo Clinic | 2012-07-09 |
| Lapatinib Ditosylate, Trastuzumab, Paclitaxel, and Surgery in Treating Patients With Breast Cancer (NCT01688609) | National Cancer Institute (NCI) | 2012-07-01 |
| Exercise Program for Early Breast Cancer Survivors (NCT01140282) | University of Southern California | 2012-05-21 |
| Vascular and Cognitive Assessments in Patients With Breast Cancer Undergoing Chemotherapy After Surgery (NCT01483196) | Wake Forest University Health Sciences | 2012-01-01 |
| FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast Cancer (NCT01931709) | University of Washington | 2011-11-01 |
| Omega-3 Fatty Acids in Preventing Joint Symptoms in Patients With Stage I-III Breast Cancer Receiving Anastrozole, Exemestane, or Letrozole (NCT01478477) | Ohio State University Comprehensive Cancer Center | 2011-10-04 |
| Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer (NCT01368263) | Washington University School of Medicine | 2011-09-01 |
| Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients (NCT01372579) | Northwestern University | 2011-08-01 |
| Neo-adjuvant Therapy With Anastrozole Plus Pazopanib in Stage II and III ER+ Breast Cancer (NCT01394211) | University of Arizona | 2011-07-13 |
| Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast Cancer (NCT01355393) | University of Washington | 2011-07-01 |
| Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer (NCT01293032) | Virginia Commonwealth University | 2011-04-01 |
| A Study of Vorinostat and Tamoxifen in Newly Diagnosed Breast Cancer (NCT01194427) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2011-03-01 |
| Trial With Autologous Dendritic Cell Vaccination in Patients With Stage II-III HER2 Negative Breast Cancer (NCT01431196) | Clinica Universidad de Navarra, Universidad de Navarra | 2011-02-01 |
| Diindolylmethane in Treating Patients With Breast Cancer (NCT01391689) | University of Arizona | 2011-02-01 |
| Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms (NCT01194440) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2011-02-01 |
| Stereotactic Image-Guided Navigation During Breast Reconstruction in Patients With Breast Cancer (NCT01729832) | Ohio State University Comprehensive Cancer Center | 2011-01-10 |
| Azacitidine in Treating Patients With Triple Negative Stage I-IV Invasive Breast Cancer That Can Be Removed By Surgery (NCT01292083) | University of Southern California | 2011-01-01 |
| Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer (NCT01417286) | Rutgers, The State University of New Jersey | 2010-12-21 |
| Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients. (NCT01276054) | University of Southern California | 2010-12-01 |
| Cryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Receiving Paclitaxel (NCT01243541) | Northwestern University | 2010-11-03 |
| RO4929097 and Letrozole in Treating Post-Menopausal Women With Hormone Receptor-Positive Stage II or Stage III Breast Cancer (NCT01208441) | National Cancer Institute (NCI) | 2010-11-01 |
| Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors (NCT01233505) | National Cancer Institute (NCI) | 2010-10-01 |
| Entinostat and Anastrozole in Treating Postmenopausal Women With TNBC That Can Be Removed by Surgery (NCT01234532) | University of Maryland, Baltimore | 2010-10-01 |
| Endoscopic Breast Surgery in Treating Patients With Breast Cancer (NCT01222377) | University of Southern California | 2010-09-01 |
| Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer (NCT01219075) | University of Southern California | 2010-07-01 |
| Breast-Conserving Surgery Followed by Radiation Therapy With MRI-Detected Stage I or Stage II Breast Cancer (NCT01100489) | Case Comprehensive Cancer Center | 2010-02-01 |
| Rosuvastatin in Treating Women With Cardiovascular Complications Who Are Undergoing Chemotherapy For Breast Cancer (NCT01051401) | Wake Forest University Health Sciences | 2010-01-01 |
| Acupuncture in Treating Nerve Pain in Patients With Stage I, Stage II, or Stage III Breast Cancer Who Are Receiving Paclitaxel (NCT01050075) | City of Hope Medical Center | 2010-01-01 |
| MUC1 Vaccine for Triple-negative Breast Cancer (NCT00986609) | Joseph Baar, MD, PhD | 2009-08-19 |
| Acupuncture in Treating Women With Stage I, Stage II, or Stage III Breast Cancer With Aromatase Inhibitor-Related Joint Pain (NCT01013337) | Abramson Cancer Center at Penn Medicine | 2009-05-01 |
| Educational Counseling in Improving Communication and Quality of Life in Spouses and Breast Cancer Patients (NCT01723943) | University of Washington | 2009-03-01 |
| Chemotherapy & Bevacizumab for Human Epidermal Growth Factor Receptor 2 (HER2)/Neu-Negative Stage II/III Breast Cancer (NCT00679029) | University of Nebraska | 2008-05-02 |
| Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting (NCT00618657) | University of California, Irvine | 2008-02-01 |
| Defined Green Tea Catechin Extract in Treating Women With Hormone Receptor Negative Stage I-III Breast Cancer (NCT00516243) | National Cancer Institute (NCI) | 2007-07-01 |
| Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery (NCT00513292) | National Cancer Institute (NCI) | 2007-07-01 |
| Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer (NCT00513695) | University of Washington | 2007-06-01 |
| Tipifarnib and Combination Chemotherapy in Treating Patients With Stage II or Stage III Breast Cancer (NCT00470301) | National Cancer Institute (NCI) | 2007-04-01 |
| Vitamin D Deficiency, Muscle Pain, Joint Pain, and Joint Stiffness in Postmenopausal Women Receiving Letrozole For Stage I-III Breast Cancer (NCT00416715) | University of Washington | 2006-10-01 |
| Bilingual Breast Cancer Educational Intervention for Hispanic Women With Stage I, Stage II, or Stage III Breast Cancer and Their Families or Caregivers (NCT01043003) | City of Hope Medical Center | 2006-08-01 |
| Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast Cancer (NCT00343863) | University of Washington | 2006-01-01 |
| Extent of Breast Cancer and the Role of Pre-Operative Sonography and MRI (NCT02587663) | University of Southern California | 2005-11-20 |
| Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer (NCT00119262) | National Cancer Institute (NCI) | 2005-10-01 |
| Vorinostat in Treating Women Who Are Undergoing Surgery For Newly Diagnosed Stage I -III Breast Cancer (NCT00262834) | National Cancer Institute (NCI) | 2005-10-01 |
| Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer (NCT00194792) | University of Washington | 2005-08-01 |
| Capecitabine in Women With Operable Breast Cancer (NCT00148720) | Dana-Farber Cancer Institute | 2004-09-01 |
| Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery (NCT00194779) | University of Washington | 2003-10-01 |
| Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer (NCT00146562) | Harold J. Burstein, MD, PhD | 2003-07-01 |